About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Updated Non-Confidential Presentation CEO USA Roadshow

August 13, 2018

Click here to read more

Post navigation

Newsletter – August 2018

Phosphagenics Receives Arbitration Update from SIAC

Related Posts

Avecho commences CBD softgel manufacturing for pivotal Phase III insomnia study

May 17, 2023May 17, 2023

Quarterly Shareholder Update

July 1, 2015

TPM® Enhances Cannabinoid Bioavailability in Comparative Canine Study

September 19, 2022September 19, 2022

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.